Prediction of recurrence using hematologic and urinary markers in intravesical Bacillus calmette Guerin treated bladder cancer
Abstract Intravesical bacillus Calmette-Guérin (BCG) therapy reduces recurrence in non-muscle invasive bladder cancer (NMIBC). Various scoring models have been developed to predict recurrence, and this study aims to improve them by analyzing hematologic parameters and urinary immune cells. This stud...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14974-1 |
